0.9% Sodium Chloride Injection, USP, 100 mL Single-Dose Container bag, Rx Only, Nephron Pharmaceuticals Corporation, 4500 12th St. Extension, W. Columbia, SC 29172, NDC: 0487-4301-10, UPC 3 04874 30110 3.
Published February 1, 2023 · Recall initiated: January 12, 2023
Summary
FDA records drug Class II recall D-0177-2023, published February 1, 2023 and initiated January 12, 2023. Recalling firm: Nephron Sc Inc; Status: Terminated; Reported quantity: 378 bags; Lot: Lot: 271043, Exp. 03/2023. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
CGMP Deviations: potential for trace amounts of product carryover.
What to do
Voluntary: Firm initiated · Letter
Get an email if SODIUM CHLORIDE has another recall
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Brand
- SODIUM CHLORIDE
- Manufacturer
- Nephron Sc Inc
- Distributor
- Nationwide in the USA
- UPC
- 0304874301257
- Lot
- Lot: 271043, Exp. 03/2023
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDA0.9% Sodium Chloride Injection, USP, 100 mL Partial Fill in 150 mL PAB Container, Sterile, Rx only, B. BraunSeptember 16, 2026
- FDA0.9% Sodium Chloride Injection USP 500 mL, VIAFLEX Plastic Containers, with 24 units per case. BaxterSeptember 9, 2026
- FDA0.9% Sodium Chloride Injection, USP, 10 mL Ampules, Rx only, Single Dose, Preservative Free, Manufactured for:April 22, 2026
- FDA0.9% Sodium Chloride Injection, USP, 0.9% (900 mg per 100 mL) (9 mg per mL) 100 mL in a 100 mL freeflex bag,April 15, 2026
- FDAS2 Racepinephrine Inhalation Solution, USP 2.25% Bronchodilator 30x0.5 mL Sterile Unit-of-Use Vials each in aFebruary 1, 2023
- FDASterile Water for Injection, USP, For Drug Diluent Use Only, 5 mL Single-Dose Vial, packaged in 30 x 5 mLFebruary 1, 2023
Questions about this recall
Was 0.9% Sodium Chloride Injection, USP, 100 mL Single-Dose Container bag, Rx Only, Nephron Pharmaceuticals Corporation, 4500 12th St. Extension, W. Columbia, SC 29172, NDC: 0487-4301-10, UPC 3 04874 30110 3. recalled?
Yes. FDA published recall D-0177-2023 on February 1, 2023. Reported hazard: CGMP Deviations: potential for trace amounts of product carryover.
What should I do if I have this product?
Voluntary: Firm initiated · Letter
How do I know if my unit is part of the recall?
Compare your product details with the notice. Brand: SODIUM CHLORIDE. UPC: 0304874301257.